DMCC Speciality Chemicals Approves Q1 FY27 Results

DMCC Speciality Chemicals announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This decision followed a board meeting held today, August 10, 2026, ensuring compliance with market regulations.

The company’s Board of Directors considered and officially approved these financial outcomes, which included the associated Limited Review Reports issued by their Statutory Auditors. This process adheres to the stipulations outlined in Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015.

Key Meeting Details

• Meeting Date: August 10, 2026
• Financial Period Covered: Quarter ended June 30, 2026
• Meeting Commencement: 12:30 PM (IST)
• Meeting Conclusion: 2:55 PM (IST)

The approved results are now publicly accessible on the company’s official website at www.dmcc.com, providing transparency to investors and stakeholders. These details were submitted to BSE as part of the company’s regulatory filings.

Separately, Aryaman Capital Markets also informed stakeholders about the outcomes of its own board meeting. Specific details regarding decisions from Aryaman Capital Markets’ meeting were not provided in the initial reports.

These regulatory disclosures highlight the ongoing commitment of listed entities to timely financial reporting and adherence to SEBI’s governance standards, offering critical updates to the market.